Generalized Anxiety Disorder
📧 Sign up to get email alerts when something new happens for Generalized Anxiety Disorder.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2017-12-19FDA Approved: VENLAFAXINE HYDROCHLORIDE — Supplemental Application (Vertical Pharmaceuticals, LLC)
The FDA approved a supplemental application for venlafaxine hydrochloride from Vertical Pharmaceuticals, LLC.
-
FDA approval · 2017-10-11FDA Approved: LYRICA CR — Original Application (Viatris Specialty LLC)
FDA approves LYRICA CR (pregabalin) under an Original Application for an extended-release formulation of pregabalin.
-
FDA approval · 2017-10-05FDA Approved: VENLAFAXINE HYDROCHLORIDE — Original Application (Macleods Pharmaceuticals Limited)
FDA approves Macleods Pharmaceuticals Limited's venlafaxine hydrochloride original application (generic), expanding access to treatment for …
-
FDA approval · 2017-08-18FDA Approved: PAROXETINE — Original Application (Solco Healthcare LLC)
FDA approves the original generic application for Paroxetine (Solco Healthcare LLC).
-
FDA approval · 2017-05-18FDA Approved: DULOXETINE — Original Application (Solco Healthcare US, LLC)
FDA approved Solco Healthcare US, LLC's original application for duloxetine, enabling the marketing of a generic duloxetine product.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2017-05-17FDA Approved: ESCITALOPRAM OXALATE — Original Application (Amneal Pharmaceuticals LLC)
FDA approved Amneal Pharmaceuticals' original application for escitalopram oxalate, a generic version of escitalopram used to treat major de…
-
FDA approval · 2017-04-28FDA Approved: PAROXETINE — Supplemental Application (Padagis US LLC)
The FDA has approved a supplemental application for paroxetine filed by Padagis US LLC. This notice indicates FDA approval of an amendment t…
-
FDA approval · 2017-04-06FDA Approved: DULOXETINE — Supplemental Application (Zydus Lifesciences Limited)
The FDA approved a supplemental application for duloxetine submitted by Zydus Lifesciences Limited, advancing the regulatory status of the g…
-
FDA approval · 2017-03-31FDA Approved: ALPRAZOLAM — Supplemental Application (Hikma Pharmaceuticals USA Inc.)
The FDA approved a supplemental application for Alprazolam from Hikma Pharmaceuticals USA Inc., authorizing sale of a generic alprazolam pro…
-
FDA approval · 2017-03-24FDA Approved: VENLAFAXINE HYDROCHLORIDE — Original Application (Westminster Pharmaceuticals, LLC)
FDA approved a generic venlafaxine hydrochloride product from Westminster Pharmaceuticals, LLC under an Original Application. This approval …
-
FDA approval · 2017-03-23FDA Approved: DULOXETINE HYDROCHLORIDE — Original Application (Macleods Pharmaceuticals Limited)
FDA approved the original application for duloxetine hydrochloride from Macleods Pharmaceuticals Limited, authorizing a generic version of d…
-
FDA approval · 2017-01-20FDA Approved: PAROXETINE — Original Application (Lupin Pharmaceuticals, Inc.)
FDA approved Lupin Pharmaceuticals' original application for Paroxetine, a generic selective serotonin reuptake inhibitor. The approval expa…
-
FDA approval · 2017-01-06FDA Approved: DULOXETINE — Original Application (Quallent Pharmaceuticals Health LLC)
FDA approved an Original Application (ANDA 208706) for duloxetine from Quallent Pharmaceuticals Health LLC, establishing a generic version o…
-
FDA approval · 2017-01-04FDA Approved: CYMBALTA — Supplemental Application (Eli Lilly and Company)
FDA approved a supplemental application for Cymbalta (duloxetine hydrochloride) from Eli Lilly and Company.
-
FDA approval · 2017-01-04FDA Approved: LEXAPRO — Supplemental Application (Allergan, Inc.)
The FDA approved a supplemental application for Lexapro (escitalopram) filed by Allergan, Inc. This is a supplemental approval of the NDA.
-
FDA approval · 2017-01-04FDA Approved: VENLAFAXINE HYDROCHLORIDE — Supplemental Application (Vertical Pharmaceuticals, LLC)
The FDA approved a supplemental application for venlafaxine hydrochloride from Vertical Pharmaceuticals, LLC, likely related to labeling cha…
-
FDA approval · 2017-01-04FDA Approved: VENLAFAXINE — Supplemental Application (Sun Pharmaceutical Industries, Inc.)
FDA approved a supplemental application for Venlafaxine from Sun Pharmaceutical Industries, Inc., indicating approval of a change to the exi…
-
FDA approval · 2017-01-04FDA Approved: VENLAFAXINE — Supplemental Application (Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.)
FDA approved a supplemental ANDA for venlafaxine by Heritage Pharmaceuticals (Avet) to bring a generic version to the market.
-
FDA approval · 2017-01-04FDA Approved: VENLAFAXINE — Supplemental Application (Aurobindo Pharma Limited)
FDA approved a supplemental application for venlafaxine hydrochloride (generic venlafaxine) from Aurobindo Pharma Limited.
-
FDA approval · 2017-01-04FDA Approved: VENLAFAXINE — Supplemental Application (Alembic Pharmaceuticals Inc.)
FDA approved a supplemental application for Venlafaxine from Alembic Pharmaceuticals Inc. under an approved ANDA.
-
FDA approval · 2017-01-04FDA Approved: VENLAFAXINE — Supplemental Application (BluePoint Laboratories)
The FDA approved a supplemental application from BluePoint Laboratories for Venlafaxine (venlafaxine hydrochloride), a generic antidepressan…
-
FDA approval · 2017-01-04FDA Approved: VENLAFAXINE HYDROCHLORIDE — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
FDA approved a supplemental application for venlafaxine hydrochloride (venlafaxine HCl) from Teva Pharmaceuticals USA, Inc.
-
FDA approval · 2016-12-22FDA Approved: LYRICA — Supplemental Application (Parke-Davis Div of Pfizer Inc)
The FDA approved a supplemental application for LYRICA (pregabalin) submitted by Parke-Davis Division of Pfizer Inc.
-
FDA approval · 2016-12-16FDA Approved: CHLORDIAZEPOXIDE AND AMITRIPTYLINE HYDROCHLORIDE — Supplemental Application (Mylan Pharmaceuticals Inc.)
FDA approved a supplemental application for the generic chlordiazepoxide and amitriptyline hydrochloride combination from Mylan Pharmaceutic…
-
FDA approval · 2016-12-16FDA Approved: ALPRAZOLAM — Supplemental Application (Mylan Pharmaceuticals Inc.)
FDA approved a supplemental application for alprazolam from Mylan Pharmaceuticals Inc., authorizing changes to the product under the NDA.